The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than ...

Trixeo/Breztri, is approved in the US for treatment of asthma, with regulatory filings currently under review in other major ...

ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, has appointed Hitesh ...

A supplemental New Drug Application (sNDA) for Pfizer’s Talzenna (talazoparib) in combination with Xtandi (enzalutamide) has ...

Takeda has announced new data from the two pivotal phase 3 studies of zasocitinib (TAK-279) in adults with moderate-to-severe ...

Veradermics has announced positive topline results from its open-label phase 2 clinical trial (Study ‘207’) evaluating ...

Almirall’s submission to extend its Marketing Authorisation Application (MAA) for Ebglyss (lebrikizumab) to treat moderate-to ...

How do we translate individual experiences into support that helps others and create support that feels personal but remains ...

Independent network The Bloc has appointed Jon Chapman as European Executive Creative Director. Chapman previously held ...

AstraZeneca has entered into an exclusive licence agreement with Dizal Pharmaceutical for Zegfrovy (sunvozertinib), a novel ...

Following ASCO® 2026, Inizio's experts have shared their perspectives across three thought leadership articles, each ...

The unique combination of technology marks 25 years of industry innovation and expertise, and signals company’s next phase of ...